{"schema_version":"secwatch.filing_event.v1","accession":"0001127537-23-000042","form_type":"8-K","ticker":"LUNG","cik":"0001127537","company_name":"Pulmonx Corp","filed_at":"2023-10-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:28.298571+00:00","generated_at":"2026-06-09T05:37:38.909060+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Pulmonx Q3 revenue $17.7M record +31% YoY; raises FY2023 guidance to $67-68M","bullets":["Record worldwide revenue $17.7M (+31% YoY); U.S. revenue $11.8M (+41% YoY).","Net loss $14.9M ($0.39 EPS) vs $14.2M ($0.38 EPS) in Q3 2022.","Raised 2023 revenue guidance to $67-68M (prior $64-66M); gross margin ~74%.","Adjusted EBITDA loss improved to $9.0M from $9.7M YoY.","Japan MHLW approved Zephyr Valve reimbursement for severe COPD/emphysema."],"urls":{"canonical":"https://secwatch.observer/filing/0001127537-23-000042","json":"https://secwatch.observer/filing/0001127537-23-000042.json","markdown":"https://secwatch.observer/filing/0001127537-23-000042.md","text":"https://secwatch.observer/filing/0001127537-23-000042.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1127537/000112753723000042/0001127537-23-000042-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1127537/000112753723000042/lung-20231030.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-09T05:37:38.909060+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"72ae6601fc45ede74515be9cbedcb0019aa83d8d","claim":"Pulmonx Corp reported the third quarter of 2023 ended September 30, 2023 results: revenue $17.7 million, net income $14.9 million, EPS $0.39 per share. Guidance raised.","evidence_excerpt":"Total worldwide revenue in the third quarter of 2023 was $17.7 million","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1127537/000112753723000042/0001127537-23-000042-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the third quarter of 2023 ended September 30, 2023"},{"label":"Revenue","value":"$17.7 million"},{"label":"Net income","value":"$14.9 million"},{"label":"EPS","value":"$0.39 per share"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}